Concepedia

Sheldon W. Tobe

SW

Statistics

Publications

129

Citations

15.5K

H-Index

54

Active since

1991

Affiliations

Sunnybrook Health Science Centre(Current)

University of Toronto

Health Sciences Centre

University of Calgary

University of Ottawa

Sheldon W. Tobe is an author at Sunnybrook Health Science Centre specializing in medicine, hypertension management, and blood pressure management.

ORCID

Publications per year

1991–2025

129

Publications

129

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

, , +14

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Alfred K. Cheung, Tara I. Chang, William C. Cushman et al. · Kidney International · 2021 · 1.4K citations

, , +17

Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

Adeera Levin, Christopher Thompson, Jean Éthier et al. · American Journal of Kidney Diseases · 1999 · 837 citations

, , +12

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

, , +15

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

, , +10

1–5 of 129